Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma

  • Khor, Goot Heah (Centre of Preclinical Science Studies, Faculty of Dentistry, Universiti Teknologi MARA, Sungai Buluh Campus) ;
  • Froemming, Gabrielle Ruth Anisah (Institute of Pathology, Laboratory and Forensic Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buluh Campus) ;
  • Zain, Rosnah Binti (Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya) ;
  • Abraham, Thomas Mannil (Tengku Ampuan Rahimah Hospital, Department of Oral and Maxillofacial Surgery, Ministry of Health Malaysia) ;
  • Lin, Thong Kwai (Institute of Biological Science, Faculty of Science, University of Malaya)
  • 발행 : 2016.02.05


Background: Promoter hypermethylation is a frequent epigenetic mechanism for gene transcription repression in cancer and is one of the hallmarks of the disease. Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3) contributes to cell contact-mediated communication. Dysregulation of promoter methylation has been reported in various cancers. Objectives: The objectives of this study were to investigate the CELSR3 hypermethylation level in oral squamous cell carcinomas (OSCCs) using methylation-sensitive high-resolution melting analysis (MS-HRM) and to correlate CELSR3 methylation with patient demographic and clinicopathological parameters. Materials and Methods: Frozen tissue samples of healthy subjects' normal mucosa and OSCCs were examined with regard to their methylation levels of the CELSR3 gene using MS-HRM. Results: MS-HRM analysis revealed a high methylation level of CELSR3 in 86% of OSCC cases. Significant correlations were found between CELSR3 quantitative methylation levels with patient ethnicity (P=0.005), age (P=0.024) and pathological stages (P=0.004). A moderate positive correlation between CELSR3 and patient age was also evident (R=0.444, P=0.001). Conclusions: CELSR3 promoter hypermethylation may be an important mechanism involved in oral carcinogenesis. It may thus be used as a biomarker in OSCC prognostication.


CELSR3;hypermethylation;oral squamous cell carcinoma;biomarker


연구 과제 주관 기관 : Universiti Teknologi MARA, Ministry of Higher Education


  1. Amornpisutt R, Sriraksa R, Limpaiboon T (2012). Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma. Clin Biochem, 45, 1092-4.
  2. Baylin SB, Ohm JE (2006). Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nature Rev Cancer, 6, 107-16.
  3. Cianfrocca M, Goldstein LJ (2004). Prognostic and predictive factors in early-stage breast cancer. The Oncologist, 9, 606-16.
  4. Dobrowolski SF, Wittwer CT (2011). High-resolution melt profiling, in molecular analysis and genome discovery. John Wiley & Sons, Ltd, p. 81-113.
  5. Einav Nili GY, Saito Y, Egger G, et al (2008). Cancer epigenetics, modifications, screening, and therapy. Annu Rev Med, 59, 267-80.
  6. Erkan M, Weis N, Pan Z, et al (2010). Organ-, inflammation-and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer, 9, 88-103.
  7. Feng, J, Han Q, Zhou L (2012). Planar cell polarity genes, Celsr1-3 in neural development. Neurosci Bulletin, 28, 39-15.
  8. Herman JG, Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. New Engl J Med, 349, 2042-54.
  9. Jemal A, Siegel R, Ward E (2007). Ca_statistica. CA Cancer J Clin, 57, 43-66.
  10. Jeong P, Ha YS, Cho IC, et al (2011). Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. Oncol Lett, 2, 679-84.
  11. Katoh M (2005). WNT/PCP signaling pathway and human cancer (Review). Oncol Reports, 14, 1583-8.
  12. Katoh M, Katoh M (2007). Comparative integromics on noncanonical WNT or planar cell polarity signaling molecules, Transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells. Inter J Mol Med, 20, 405-9.
  13. Khor GH, Froemming GRA, Zain RB, et al (2013). DNA methylation profiling revealed promoter hypermethylationinduced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Inter J Med Sci, 10, 1727-39.
  14. Khor GH, Froemming GRA, Zain RB, et al (2014). Screening of differential promoter hypermethylated genes in primary oral squamous cell carcinoma. Asian Pacific J Cancer Prev, 15, 8957-61.
  15. Mascolo M, Siano M, Ilardi G, et al (2012). Epigenetic disregulation in oral cancer. Int J Mol Sc, 13, 2331-53.
  16. Montgomery JL, Sanford LN, Wittwer CT (2010). Highresolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn, 10, 219-40.
  17. Morris MR, Ricketts CJ, Gentle D, et a (2010). Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene, 30, 1390-401.
  18. Pimenta Amaral TM, da Silva Freire AR, Carvalho AL, et al (2004). Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol, 40, 780-6.
  19. Reed GH, Kent JO, Wittwer CT (2007). High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics, 8, 597-608.
  20. Shen J, Wang S, Zhang YJ, et al (2012). Genome wide DNA methylation profiles in hepatocellular carcinoma. Hepatology, 55, 1799-808.
  21. Tian XY, Zhang L, Sun LG, et al (2015). Epigenetic Regulation of miR-129-2 Leads to Overexpression of PDGFRa and FoxP1 in Glioma Cells. Asian Pac J Cancer Prev, 16, 6129-33.
  22. Tissir F, Bar I, Jossin Y, et al (2005). Protocadherin Celsr3 is crucial in axonal tract development. Nature Neurosci, 8, 451-7.
  23. Wittwer CT (2009). High-resolution DNA melting analysis. advancements and limitations. Hum Mutat, 30, 857-9.
  24. Wojdacz TK, Dobrovic A (2007). Methylation-sensitive high resolution melting (MS-HRM), a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res, 35, 41.
  25. Wojdacz TK, Dobrovic A, Hansen LL (2008). Methylationsensitive high-resolution melting. Nature Protoc, 3, 1903-8.
  26. Wojdacz TK, Borgbo T, Hansen LL (2009). Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics, 4, 231-4.
  27. Wojdacz TK, Moller TH, Thestrup BB, et al (2010). Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies. Expert Rev Mol Diagn, 10, 575-80.

피인용 문헌

  1. MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis vol.6, pp.8, 2017,
  2. MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5 vol.97, pp.5, 2017,
  3. Transcriptomic response of breast cancer cells to anacardic acid vol.8, pp.1, 2018,
  4. Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature pp.1758-535X, 2018,